Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 70.31
-1.29 (-1.80%)
At close: Mar 27, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 926.33 million as of March 27, 2026. Its market cap has increased by 190.39% in one year.
Market Cap
926.33M
Enterprise Value
1.11B
Revenue
512.41M
Ranking
n/a
PE Ratio
154.67
Stock Price
70.31
Market Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 926.33M, an increase of 539.72%. That is a compound annual growth rate of 18.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 926.33M | -14.76% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coral Laboratories | 1.36B |
| Bilcare | 1.24B |
| Pharmaids Pharmaceuticals | 1.12B |
| Lactose (India) | 1.07B |
| Bal Pharma | 1.07B |
| Mercury Laboratories | 973.20M |
| Makers Laboratories | 896.56M |
| Source Natural Foods and Herbal Supplements | 752.48M |